BridgeBio Pharma, Inc. financial data

Symbol
BBIO on Nasdaq
Location
Palo Alto, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 29 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 453 % +9.1%
Quick Ratio 6.69 %
Debt-to-equity -156 % +2%
Operating Margin -172 % +31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 192,708,813 shares +2%
Common Stock, Shares, Outstanding 192,633,286 shares +1.9%
Entity Public Float 3,729,400,000 USD +79.7%
Common Stock, Value, Issued 200,000 USD +2.6%
Weighted Average Number of Shares Outstanding, Basic 191,854,152 shares +1.8%
Weighted Average Number of Shares Outstanding, Diluted 191,854,152 shares +1.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 353,780,000 USD +62.5%
Cost of Revenue 14,939,000 USD +5.2%
Research and Development Expense 465,886,000 USD -8%
Costs and Expenses 963,656,000 USD +26.4%
Operating Income (Loss) -609,876,000 USD -12%
Nonoperating Income (Expense) -194,108,000 USD -3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -186,482,000 USD -13.5%
Income Tax Expense (Benefit) 1,708,000 USD
Earnings Per Share, Basic -4 USD/shares -74%
Earnings Per Share, Diluted -4 USD/shares -74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 642,951,000 USD +1.4%
Marketable Securities, Current 7,939,000 USD -80.1%
Accounts Receivable, after Allowance for Credit Loss, Current 116,518,000 USD
Inventory, Net 24,527,000 USD
Assets, Current 839,382,000 USD +88.8%
Property, Plant and Equipment, Net 5,830,000 USD -33%
Operating Lease, Right-of-Use Asset 6,553,000 USD +1.8%
Intangible Assets, Net (Excluding Goodwill) 28,795,000 USD +17.4%
Other Assets, Noncurrent 25,522,000 USD +25.8%
Assets 998,250,000 USD +50.1%
Accounts Payable, Current 18,702,000 USD +40%
Employee-related Liabilities, Current 56,155,000 USD +29%
Contract with Customer, Liability, Current 9,087,000 USD
Liabilities, Current 216,600,000 USD +55.6%
Contract with Customer, Liability, Noncurrent 13,131,000 USD
Operating Lease, Liability, Noncurrent 3,427,000 USD -41.2%
Other Liabilities, Noncurrent 679,000 USD +80.1%
Liabilities 2,920,979,000 USD +55.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2,000 USD -60%
Retained Earnings (Accumulated Deficit) -3,628,331,000 USD -28.2%
Stockholders' Equity Attributable to Parent -1,933,070,000 USD -57.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1,922,752,000 USD -57.7%
Liabilities and Equity 998,250,000 USD +50.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -199,235,000 USD +9.2%
Net Cash Provided by (Used in) Financing Activities 60,328,000 USD -78.4%
Net Cash Provided by (Used in) Investing Activities -1,595,000 USD -1.1%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 200,230,458 shares +2.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -140,502,000 USD -2.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 645,096,000 USD +58.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 23,271,000 USD -34.1%
Deferred Tax Assets, Valuation Allowance 727,326,000 USD +8.2%
Deferred Tax Assets, Gross 728,638,000 USD +7.4%
Operating Lease, Liability 8,721,000 USD -16.4%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -797,121,000 USD -81.6%
Lessee, Operating Lease, Liability, to be Paid 9,466,000 USD -18.2%
Operating Lease, Liability, Current 5,294,000 USD +15.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 582,000 USD -74.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 5,375,000 USD +5.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 745,000 USD -34.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 454,000 USD -2.2%
Deferred Tax Assets, Operating Loss Carryforwards 379,019,000 USD +5.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits 36,866,000 USD +19.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 487,000 USD +5%
Operating Lease, Payments 1,470,000 USD -7.8%
Additional Paid in Capital 2,018,335,000 USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2,600,000 USD +8.3%
Depreciation, Depletion and Amortization 1,284,000 USD -19.5%
Deferred Tax Assets, Net of Valuation Allowance 1,312,000 USD -79.7%
Share-based Payment Arrangement, Expense 138,427,000 USD +20.8%
Interest Expense 86,982,000 USD +8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%